165
Participants
Start Date
January 16, 2025
Primary Completion Date
November 30, 2031
Study Completion Date
November 30, 2031
ABBV-291
Intravenous Infusion
RECRUITING
St Vincent's Hospital Melbourne /ID# 261664, Fitzroy Melbourne
RECRUITING
Virginia Cancer Specialists - Fairfax /ID# 265082, Fairfax
RECRUITING
Carolina BioOncology Institute /ID# 265259, Huntersville
RECRUITING
Texas Oncology - Central/South Texas /ID# 270946, Austin
RECRUITING
Hadassah Medical Center-Hebrew University /ID# 261658, Jerusalem
RECRUITING
Willamette Valley Cancer Institute and Research Center /ID# 270945, Eugene
RECRUITING
Tel Aviv Sourasky Medical Center /ID# 261659, Tel Aviv
RECRUITING
START Mountain Region /ID# 267592, West Valley City
RECRUITING
Aichi Cancer Center /ID# 267471, Nagoya
RECRUITING
The Cancer Institute Hospital Of JFCR /ID# 267470, Koto-ku
Lead Sponsor
AbbVie
INDUSTRY